Gapping up
In reaction to strong earnings/guidance:
- TEUM +10%
M&A news:
- GWR +8.6% (to be acquired by Brookfield Infrastructure (BIP) and GIC for $112/share in cash, or approximately $8.4 bln)
- AMAT +3.8% (to acquire Kokusai Electric Corporation for $2.2 bln in cash from KKR)
Select Macau related names showing strength:
- WYNN +4.9%, LVS +4.2%, MLCO +3.3%, MGM +2.2%
Select China related stocks trading higher:
- BZUN +4.3%, MOMO +3.9%, CTRP +3.8%, JD +3.7%, WB +3.5%, BITA +3.2%, BABA +3.1%, VIPS +3.1%, BIDU +2.8%, CMCM +2.8%, EDU +2.3%, CAT +2.1%
Select Tech/Semiconductor related names showing strength:
- NPTN +21.1%, SWKS +7.6%, LITE +7.2%, IPHI +6.8%, MU +6.2%, STM +6.1%, ACIA +6%, QCOM +5.8%, WDC +5.7%, MRVL +5.4%, XLNX +4.9%, FNSR +4.9%, AVGO +4.9%, NVDA +4.9%, AMD +4.8%, TSM +3.9%, ASML +3.8%, LRCX +3.3%, INTC +3%, STX +2.9%, AAPL +2.7%, TXN +2.6%
Other news:
- BCYC +29.2% (announces completion of Oxurion's Phase I clinical trial evaluating the safety and tolerability of a single intravitreal injection of THR-149 in patients with diabetic macular edema)
- ATRA +5% (reports initial ATA188 Phase 1 safety results; were well tolerated with no dose-limiting toxicities)
- RTRX +4.6% (announces FDA approval of THIOLA EC 100mg and 300mg tablets for treatment of cystinuria)
- CERC +3.7% (announces positive final results of CERC-301 in the treatment of neurogenic orthostatic hypotension)
- AFMD +3.1% (to be added to Russell 2000)
- SAN +1.5% (announces planned capital actions -- include common dividends to Banco Santander, S.A., the co's sole shareholder, of $125 million per quarter) .
Analyst comments:
- PLAN +4.1% (upgraded to Buy from Neutral at Goldman)
- ETSY +3.3% (initiated with a Buy at Needham)
- TGLS +3.2% (upgraded to Strong Buy from Outperform at Raymond James)
- TPC +2.9% (upgraded to Buy from Neutral at DA Davidson)
- W +2.7% (initiated with a Buy at Needham)
- CPE +2.6% (upgraded to Overweight from Equal Weight at Barclays)
- UTHR +2.5% (upgraded to Outperform from Neutral at Credit Suisse)
- SIX +2.3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- FIVE +2% (resumed with an Overweight at Morgan Stanley)